Skip to content

Market explorer

Screen the results we have checked

Search and filter our published results. This is selected coverage, not a screen of every listed stock.

Read the basis before comparing. Revenue is the company's reported revenue line, not a standardised comparable measure. Excise, acquisitions, exceptional items and different reporting periods can change growth. Missing revenue or growth is not zero. Each result below keeps its filing basis and caveats. No live prices, valuation filters or recommendations.

1 matching results out of 156 published entries. 69 have revenue growth available.

Apollo Hospitals Enterprise

+23.04% revenue YoY

Q2 FY2027 · Period ended 30 Sep 2026

Basis: Consolidated, as printed in the company's Q2 FY27 results release

Reported revenue (₹ crore): 7,615

Read summary and comparison caveats

Apollo Hospitals' September-quarter consolidated revenue rose 23% year on year to ₹7,615 crore, company-defined EBITDA rose 29% to ₹1,191 crore and reported PAT rose 32% to ₹630 crore. Hospital occupancy improved to 73% from 69% a year earlier.

  • Figures are from the company's Q2 FY27 results release linked on apollohospitals.com's investor-relations page, read in full on 14 Nov 2026. The release prints quarter and half-year figures only; no previous-quarter (QoQ) column is published, so QoQ is not shown.
  • EBITDA is company-defined; percentage changes in brackets are computed by Fistotex from the printed values.
  • AHLL completed the transfer of its stake in ASPL and AFCPL to Kids Clinic India Ltd on 12 Oct 2026; under Ind AS 105 those businesses are classified as discontinued operations and comparatives re-presented. The release notes financials up to EBIT are re-presented, while PBT and PAT include discontinued operations.
  • EPS is diluted, from continuing operations, and not annualised.

Checked 14 Nov 2026

Open original filing
Read the complete published results desk